Qiwu Zhao
5PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Nov 11, 2022
Editorial: Apatinib and Anlotinib in the Treatment of Radioactive Iodine Refractory and Highly Invasive Thyroid Carcinoma.Wenqing Jia, Zhuoran Liu, Ling Zhan
|Feb 20, 2022
The central role of a two-way positive feedback pathway in molecular targeted therapies-mediated pyroptosis in anaplastic thyroid cancer.Qiwu Zhao, Haoran Feng, Zheyu Yang
|Sep 07, 2021
FOXK2 transcriptionally activating VEGFA induces apatinib resistance in anaplastic thyroid cancer through VEGFA/VEGFR1 pathway.Haoran Feng, Zhijian Jin, Juyong Liang
|Jun 05, 2021
The role of anlotinib-mediated EGFR blockade in a positive feedback loop of CXCL11-EGF-EGFR signalling in anaplastic thyroid cancer angiogenesis.Juyong Liang, Zhijian Jin, Jie Kuang
|Oct 24, 2020
FGFR3△7-9 promotes tumor progression via the phosphorylation and destabilization of ten-eleven translocation-2 in human hepatocellular carcinoma.Zhijian Jin, Haoran Feng, Juyong Liang
Pageof 1
